Agenda 2019


8:00 am	REGISTRATION AND BREAKFAST
8:25 am	Erle Robertson Ph.D., Vice Chair of Otorhinolaryngology–Head and Neck Surgery, Professor of Microbiology Perelman School of Medicine, University of Pennsylvania ♦ Opening Remarks
First Session	Robert Yarchoan, MD, NIH/ National Cancer Institute ♦ Moderator of first session
8:30–9:00 am	Sumita Bhaduri-McIntosh, MD, PhD, Associate Professor, Pediatrics & Molecular Genetics and Microbiology, University of Florida ♦ “Diabetes-related Inflammasome Components Trigger the Replication switch of Epstein-Barr virus”
9:00–9:15 am	Claude Krummenacher, PhD, Assistant Professor, Rowan University ♦ “Interaction between the HSV receptor nectin-1 and the natural killer cell receptor CD96”
9:15–9:30 am	Jason Lamontagne, PhD, P. Lieberman lab, The Wistar Institute ♦ "Integrated analysis of EBV reprogramming of primary B cells"
9:30–9:45 am♦	Megan Lloyd, PhD, J. Moffat Lab, SUNY Upstate Medical University ♦ “A novel human skin tissue model to study HCMV and evaluate antiviral drugs in vivo”
9:45–10:00 am	Joseph Dybas, PhD, Matthew D Weitzman Lab, Perelman School of Medicine ♦ “Quantitative proteomics reveals host protein targets of HSV ICP0-mediated ubiquitin”
10:00–10:30 am	COFFEE BREAK
Second Session	Ileana M Cristea, PhD, Professor of Molecular Biology at Princeton University ♦ Moderator of second session
10:30–11:30 am	Lawrence S. Young, PhD, Pro-Dean, Warwick Medical School, Director of the Warwick Cancer Research Centre, University of Warwick, UK ♦ Gertrude and Werner Henle Lectureship Keynote Speaker ♦ “The role of Epstein-Barr virus in Nasopharyngeal Carcinoma: lessons in cancer pathogenesis and treatment”
11:30–11:45 am	Hyun Jin Kwun, Ph.D. Assistant Professor Department of Microbiology and Immunology Penn State University College of Medicine ♦ “Surface charge of Merkel cell polyomavirus small t antigen: a key determinant of cell transformation"
11:45–12:00 am	Robert Yarchoan, MD, Senior Investigator HIV and AIDS Malignancy Branch, National CanceRobert Yarchoan, MD, Senior Investigator HIV and AIDS Malignancy Branch, National Cancer Instituter Institute ♦ “Activation of KSHV vIL-6 (ORF K2) and thymidine kinase (ORF21) by spliced XBP-1: Implications for pathogenesis and therapy”
12:00–1:15 pm	LUNCH
Third session	Paul Lieberman, PhD, Hilary Koprowski, M.D., Endowed Professor The Wistar Institute ♦ Moderator of third session
1:15–1:45 pm	Robert P. Ricciardi, MA, PhD, Chair and Professor of Department of Microbiology Penn Dental ♦ “Developing an Antiviral Stapled-Peptide to Treat Herpes Ocular Keratitis, the Leading Cause of Blindness in the World”
1:45–2:00 pm	Sean Lawler, PhD, Assistant Professor at Brigham and Women's Hospital ♦ “Cytomegalovirus promotes brain tumor growth via pericyte recruitment and angiogenesis”
2:00–2:15 pm	Kai Wu, PhD, Thomas Shenk Lab, Department of Molecular Biology, Princeton University ♦ “Friend or Foe? PDGF receptor alpha as a cellular receptor and an antagonist for human cytomegalovirus"
2:15–2:30 pm	Krystal Lum, Graduate Student, Ileana Cristea Lab, Princeton University ♦ “Interactome and Proteome Dynamics Uncover Antagonistic Relationship between Pathogen Sensing Factors cGAS and OASL"
2:30–2:45 pm	Daniel Depledge, PhD, Assistant Professor, New York University School of Medicine ♦ "Deciphering complex herpesviral transcriptomes using direct RNA sequencing"
2:45–3:15 pm	AFTERNOON BREAK
Final Session	Laurie Krug Lab, Stony Brook University ♦ Moderator of final session
3:15–3:45 pm	Yan Yuan, Ph.D., Professor, Department of Microbiology, University of Pennsylvania ♦ “KSHV Infection of Mesenchymal Stem Cells Leads to Kaposi's sarcoma and Osteosarcoma”
3:45–4:00 pm	Prabha Shresta PhD, Robert Yarchoan lab, NIH/NCI ♦ “Mechanisms and functional aspects of the effects of pomalidomide and related drugs on herpesvirus-induced downregulation of surface markers”
4:00–4:15 pm	Kevin Egan, PhD, Harvey M. Friedman lab, University of Pennsylvania ♦ “An HSV-2 gC2/gD2/gE2 trivalent vaccine provides cross protection against high dose intravaginal HSV-1 challenge"
4:15–4:30 pm	Kathyrn Stein, PhD Candidate, Domenico Tortorella Lab, Icahn School of Medicine at Mount Sinai ♦ “Discovery of CD46 as a cell-type cytomegalovirus entry factor”
4:30–4:45 pm	Metthew Lam, PhD, Elizabeth White lab, University of Pennsylvania ♦ “Regulation of IL-1-mediated inflammation by HPV oncoproteins”
4:45 pm	RECEPTION

Download Symposium Agenda